In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods

International Journal of Antimicrobial Agents

Volumn 35, Issue 1, 2010, Pages 68-71

  Almuzara, Marisa ^a   Limansky, Adriana ^b   Ballerini, Viviana ^b   Galanternik, Laura ^c   Famiglietti, Angela ^a   Vay, Carlos ^a  

^a University of Buenos Aires   (Argentina)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Achromobacter spp; Agar dilution; Antimicrobial susceptibility; Disk diffusion

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

ACHROMOBACTER; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ACHROMOBACTER; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 71049142114     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.08.015     Document Type: Article

References (15)

1. Schreckenberger P., and von Graevenitz A. Acinetobacter, Achromobacter, Alcaligenes, Moraxella, Methylobacterium and other non-fermentative Gram-negative rods. In: Murray P.R., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of clinical microbiology. 8th ed. (2007), American Society for Microbiology Press, Washington, DC 585-608
2. Chandrasekar P.H., Arathoon E., and Levine D.P. Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection 14 (1986) 279-282
3. Vu-Thien H., Moissenet D., Valcin M., Dulot C., Tournier G., and Garbarg-Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis 15 (1996) 876-879
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2008.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests; approved standard. 9th ed. Document M2-A9. Wayne, PA: CLSI; 2008.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
7. National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters; approved standard. Document M23-A2. Wayne, PA: NCCLS; 2001.
8. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
9. Limansky A., and Viale A. Can composition and structural features of oligonucleotides contribute to their wide-scale applicability as random PCR primers in mapping bacterial genome diversity?. J Microbiol Methods 50 (2002) 291-297
10. Gales A.C., Jones R.N., Andrade S.S., and Sader H.S. Antimicrobial susceptibility patterns of unusual nonfermentative Gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 6 (2005) 671-677
11. Fraser S., and Jorgensen J. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 41 (1997) 2738-2741
12. Fass R., and Barnishan J. In vitro susceptibilities of nonfermentative Gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis 2 (1980) 841-851
13. Sader H.S., and Jones R.N. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Int J Antimicrob Agents 25 (2005) 95-109
14. Fujii T., Sato K., Inove M., and Mitsuhashi S. Purification and properties of a β-lactamase from Alcaligenes dentrificans subsp. xylosoxydans. J Antimicrob Chemother 16 (1985) 297-304
15. Neuwirth C., Freby C., Ogier-Desserrey A., Perez-Martin S., Houzel A., Péchinot A., et al. VEB-1 in Achromobacter xylosoxidans from cystic fibrosis patient, France. Emerg Infect Dis 12 (2006) 1737-1739